Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GONADORELIN for Ovulation induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where GONADORELIN was used for Ovulation induction.

Most Reported Side Effects for GONADORELIN

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 32 14.2% 0 21
Neutropenia 31 13.8% 0 0
Metastases to bone 24 10.7% 0 3
Headache 20 8.9% 0 6
Malignant neoplasm progression 20 8.9% 0 4
White blood cell count decreased 20 8.9% 0 0
Carcinoembryonic antigen increased 15 6.7% 0 0
Breast cancer 14 6.2% 0 0
Nausea 14 6.2% 0 9
Central nervous system lesion 13 5.8% 0 6
Neutrophil count decreased 13 5.8% 0 1
Fatigue 10 4.4% 0 4
Product use in unapproved indication 10 4.4% 0 1
Rash 10 4.4% 0 4
Recalled product administered 10 4.4% 0 1

Other Indications for GONADORELIN

Product used for unknown indication (45) Breast cancer (26) Prostate cancer metastatic (25) In vitro fertilisation (22) Breast cancer metastatic (15) Assisted reproductive technology (14) Prostate cancer (13) Controlled ovarian stimulation (5) Hormone replacement therapy (5)

Other Drugs Used for Ovulation induction

CHORIOGONADOTROPIN ALFA (460) FOLLITROPIN (249) CLOMIPHENE (124) LETROZOLE (122) MENOTROPINS (107) FOLLITROPIN BETA (86) LUTROPIN ALFA (86) TRIPTORELIN (73) LEUPROLIDE (64) GONADOTROPHIN, CHORIONIC (57)

Related Pages

GONADORELIN Full Profile All Ovulation induction Drugs GONADORELIN Demographics GONADORELIN Timeline